SAB Biotherapeutics, Inc.: Revision history

20 August 2022

• curprev 16:0316:03, 20 August 2022 95.149.241.133 talk 1,171 bytes +11 No edit summary undo

14 August 2022

• curprev 00:2300:23, 14 August 2022 109.180.50.163 talk 1,160 bytes +15 No edit summary undo

31 July 2022

• curprev 02:1902:19, 31 July 2022 >Chris 1,145 bytes +1,145 Created page with "SAB Biotherapeutics, Inc., a clinical-stage biopharmaceutical company, engages in the development of immunotherapies based on human antibodies. It has applied advanced genetic engineering and antibody science to develop transchromosomic bovine herds that produce fully human antibodies targeted at specific diseases, including infectious diseases comprising COVID-19 and influenza, immune and autoimmune disorders, such as type 1 diabetes, organ transplantation, and cancer...."